BUTONG GROUP (06090) repurchased 110,000 shares for HK$3.8656 million on October 15.
BUTONG GROUP (06090) announced that on October 15, 2026, the company repurchased 110,000 shares for HK$3.8656 million, at a repurchase price of HK$35.1-35.56 per share.
BUTONG GROUP (06090) announced that on October 15, 2026, the company repurchased 110,000 shares for HK$3.8656 million, at a repurchase price of HK$35.1-35.56 per share.
Related Articles
HK Stock Market Move | ALEBUND-B(09637) rose nearly 4% at one point during intraday trading, with an amplitude of 13.53%. Hong Kong-listed innovative drug stocks strengthened collectively. AP308, a new drug for the treatment of IgA nephropathy, received approval from the U.S. FDA for clinical trials.
Jensen Huang Speaks Out: CoreWeave (CRWV.US) Midday Scare Highlights the Core Elements of Compute Operations
LEADS BIOLABS-B(09887): First Patient Dosed in Phase IB/II Clinical Trial of Vilixin (Opatilimab, PD-L1/41BB Bispecific Antibody) in Combination Therapy for Metastatic Colorectal Cancer
HK Stock Market Move | ALEBUND-B(09637) rose nearly 4% at one point during intraday trading, with an amplitude of 13.53%. Hong Kong-listed innovative drug stocks strengthened collectively. AP308, a new drug for the treatment of IgA nephropathy, received approval from the U.S. FDA for clinical trials.
Jensen Huang Speaks Out: CoreWeave (CRWV.US) Midday Scare Highlights the Core Elements of Compute Operations
LEADS BIOLABS-B(09887): First Patient Dosed in Phase IB/II Clinical Trial of Vilixin (Opatilimab, PD-L1/41BB Bispecific Antibody) in Combination Therapy for Metastatic Colorectal Cancer
